• Sign Up

Orchitis


Orchitis

Article Author:
Chaudhary Ehtsham Azmat
Article Editor:
Pradeep Vaitla
Updated:
11/4/2020 11:25:31 AM
For CME on this topic:
Orchitis CME
PubMed Link:
Orchitis

Introduction

Orchitis is defined as the inflammation of the testicle unilaterally or bilaterally usually caused by viruses and bacteria. Testes are two oval male reproductive organs situated in the scrotum. They are responsible for the production of male sex hormones and sperm. The testis is innervated by testicular plexus, which contains nerves originating from renal and aortic plexus. The main arterial supply is by paired testicular artery, arising from the abdominal aorta, which passes via the inguinal canal inside the spermatic cord. Venous drainage is through pampiniform plexus. As testis are originally retroperitoneal organs, lymphatic drainage is through para-aortic lymph nodes, while superficial inguinal lymph nodes drain the scrotum.

Orchitis can be acute and symptomatic on the presentation or asymptomatic and chronic.[1] Isolated orchitis is rare and usually accompanied by an infection of the epididymis. The major route for the spread is blood-borne dissemination for isolated orchitis.[2] Ascending infections can also involve testis.

Etiology

Various bacteria and viruses cause orchitis.

  • Orchitis in young patients is usually viral, with mumps and rubella being the most common causes. Reports exist of cases of orchitis have after the measles, mumps, and rubella (MMR) vaccine.[3]
  • Other viruses include coxsackievirus, varicella, echovirus, and cytomegalovirus.
  • Bacterial infections of the prostate and urinary tract infection can cause orchitis. Common causes of bacterial orchitis include Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus and Streptococcus species.
  • Bacteria that can cause sexually transmitted infections can also cause orchitis in sexually active males. Common organisms are Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum
  • Mycobacterium avium complex, Cryptococcus neoformans, Toxoplasma gondii, Haemophilus parainfluenzae, and Candida albicans have been reported to cause orchitis in immunocompromised patients.

There are also reports of orchitis caused by autoimmunity, which can classify as primary and secondary.[4]

Epidemiology

Orchitis alone is very uncommon and is usually accompanied by epididymitis, hence the true incidence is unclear. Current literature also does not suggest any predilection for any race or religion.

Orchitis develops in 14% to 35% postpubertal patients with mumps. Symptoms develop 4 to 8 days after parotitis but can also occur in the absence of parotitis. Mumps virus is responsible for most of the cases of isolated orchitis.

Pathophysiology

Orchitis is the inflammation of testis, and isolated acute orchitis is a very rare phenomenon.[5] Orchitis is usually unilateral, and symptoms can vary from mild to severe. Most cases resolve by the end of two weeks. There are two significant differences between orchitis and infections of other male accessory sex organs

  • The primary route of spread of infection to the testis is blood-borne dissemination.[2]
  • Viruses are implicated as significant pathogens.

Common risk factors include a preexisting history of epididymitis, unprotected sexual contact, multiple sexual partners, long term use of foley catheter, bladder outlet obstruction, structural abnormality, and lack of immunization with MMR vaccination (vaccination reduces the risk of developing orchitis after Mumps).[6]

History and Physical

The patient usually presents with acute onset of testicular pain, which may initially involve one testis, and then may spread to include the whole scrotum. The patient may also complain of fever accompanied by malaise, fatigue, and chills.

Examination findings may include testicular enlargement, tenderness, and induration. Scrotal edema and erythema may also be present. Epididymis may also be enlarged if orchitis is accompanied with epididymitis. Cremasteric reflex is normal in affected individuals. Mumps orchitis may present with bilateral parotid enlargement and usually present 4 to 8 days after onset of parotitis.

When evaluating such patients, the clinician should also note various risk factors so that they can receive appropriate management.

Evaluation

Orchitis diagnosis is usually from history and physical findings. Laboratory tests are generally not helpful, but urethral swabs and urine samples may be obtained for routine examination and cultures to rule out urinary tract infection and diagnose sexually transmitted infections as the source.

When assessing patients with acute testicular or scrotal pain, it is imperative to rule out testicular torsion. For such patients, Color Doppler ultrasonography of scrotum is the first choice of investigation.

Ultrasonography findings in patients with mumps orchitis usually subside by the seventh day.[7] Although not typically done, serum immunofluorescence antibody testing is useful to confirm the diagnosis of mumps orchitis.

Treatment / Management

In an emergency, physicians must distinguish between torsion and inflammation of the testis. Antibiotics are not necessary for viral causes of the disease, supportive therapies such as bed rest, antipyretics, analgesics, scrotal support, and hot or cold packs for analgesia are advisable.

Antibiotics should start empirically based on the likely pathogens according to age and sexual history.

  • If there is suspicion of an enteric bacteria is suspected, then fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin) for 10 to 14 days are the preferred drugs. Trimethoprim-sulfamethoxazole is also an option for these pathogens.
  • If there is suspicion of a sexually transmitted pathogen, then treatment should consist of ceftriaxone 250 mg single shot intramuscularly and doxycycline 100 mg twice daily for 10 to 14 days. Azithromycin is also an option in place of doxycycline.

Sexual partners of the patient with sexually transmitted pathogens should receive treatment.[8] The inability to take oral antibiotics, signs of sepsis and failure of previous outpatient therapy should warrant inpatient therapy.

Differential Diagnosis

Careful evaluation for probable reasons for acute scrotal pain and swelling is essential for the efficient management of the patients. Testicular torsion is the most significant differential as urgent exploration is required.[9] Other differentials include:

  • Abscess formation
  • Hydrocoele
  • Epididymitis (often coexist)

Prognosis

Overall, the majority of viral cases and antibiotic-treated cases will resolve without any complications. Most of the patients are treated as outpatients. The swelling and tenderness may persist even after antibiotic therapy but should be significantly improved. In case of persistence, compliance should be checked, and receive further evaluation if required. The decrease in body temperature in the first three days of antibacterial treatment is considered as a good prognostic marker.[10] Most cases of mumps orchitis also resolve within ten days.

Complications

Complications are preventable with accurate diagnosis and efficient management of patients.[11] Most patients recover without sequelae; however, there are reports of the following complications:

  • Testicular atrophy ( Up to 60% cases demonstrate some degree of atrophy)
  • Impaired fertility
  • Sterility (rare)
  • Epididymitis
  • Reactive hydrocele

Rarely in cases of pyogenic orchitis and testicular infarction, an abscess can be formed which require surgical consultation for management.

Consultations

The majority of cases do not require consultations. In some complicated cases, consultations may be required such as

  • Formation of abscess or infarction of testicle may require surgical consultation.
  • Infectious diseases can be consulted in the case of immune-compromised patients.
  • Urology should be consulted if there is a suspicion of torsion on presentation.

Deterrence and Patient Education

Prevention revolves primarily in avoiding the risk factors:

  •  Vaccination against mumps
  •  Safe sex practices to prevent gonorrheal and chlamydial infections
  •  Avoid indwelling urinary catheters and
  •  Surgically correct urinary tract obstructions for eligible patients

All clinical staff should advise patients to take the full course of antibiotics to prevent the emergence of resistance and recurrence.

Pearls and Other Issues

  • Samples for blood and urine culture should be taken before starting antibiotic therapy.
  • In the case of recurrence, the patient requires evaluation for the preexisting risk factors like bladder outlet obstruction.
  • The risk of antibiotic-resistant pathogens increases in patients with indwelling catheters, so in addition to a fluoroquinolone, a third-generation cephalosporin should also be given empirically while waiting for culture reports.[12]  

Enhancing Healthcare Team Outcomes

The management of orchitis is usually on an outpatient basis; severe complications are rare. The condition still merits the involvement of an interprofessional healthcare team. However, several measures can help improve the outcomes and prevent the disease.

A study conducted in England and Wales concluded that vaccination with MMR provides significantly greater protection against hospitalization and risk of orchitis in diagnosed cases of mumps.[13] So parents should be educated about the benefits of getting their children vaccinated.

Another study showed that in general practice, patients presenting with symptoms of orchitis do not usually receive testing for sexually transmitted infections.[14] This practice needs to improve as these infections affect not only the individual but also their sexual partners.

In Europe and the U.S.A, the isolates of Escherichia coli are becoming increasingly resistant to ciprofloxacin, which requires finding alternatives with sufficient penetration into testis for efficient and comprehensive management of orchitis.[15] 

Urodynamic studies should only be for patients with suspicion of urinary tract obstruction.[16]

Urology nurses are involved in the administration of treatment, patient education, and reporting back to the team. Pharmacists check medication dosage, interactions, assist the clinician with antimicrobial therapy selection, and also provide patient education. These types of interprofessional team collaboration can improve patient outcomes in cases of orchitis. [Level 5]


References

[1] Pilatz A,Fijak M,Wagenlehner F,Schuppe HC, [Orchitis]. Der Urologe. Ausg. A. 2019 Jun;     [PubMed PMID: 31111192]
[2] Krieger JN, Epididymitis, orchitis, and related conditions. Sexually transmitted diseases. 1984 Jul-Sep;     [PubMed PMID: 6390741]
[3] Kanda T,Mochida J,Takada S,Hori Y,Yamaguchi K,Takahashi S, Case of mumps orchitis after vaccination. International journal of urology : official journal of the Japanese Urological Association. 2014 Apr;     [PubMed PMID: 24164648]
[4] Silva CA,Cocuzza M,Carvalho JF,Bonfá E, Diagnosis and classification of autoimmune orchitis. Autoimmunity reviews. 2014 Apr-May;     [PubMed PMID: 24424181]
[5] Ludwig M, Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia. 2008 Apr;     [PubMed PMID: 18336454]
[6] Hahné S,Whelan J,van Binnendijk R,Swaan C,Fanoy E,Boot H,de Melker H, Mumps vaccine effectiveness against orchitis. Emerging infectious diseases. 2012 Jan;     [PubMed PMID: 22260843]
[7] Başekim CC,Kizilkaya E,Pekkafali Z,Baykal KV,Karsli AF, Mumps epididymo-orchitis: sonography and color Doppler sonographic findings. Abdominal imaging. 2000 May-Jun;     [PubMed PMID: 10823460]
[8] Manavi K,Turner K,Scott GR,Stewart LH, Audit on the management of epididymo-orchitis by the Department of Urology in Edinburgh. International journal of STD     [PubMed PMID: 15949072]
[9] Walker NA,Challacombe B, Managing epididymo-orchitis in general practice. The Practitioner. 2013 Apr;     [PubMed PMID: 23724748]
[10] Banyra O,Shulyak A, Acute epididymo-orchitis: staging and treatment. Central European journal of urology. 2012;     [PubMed PMID: 24578950]
[11] Street EJ,Justice ED,Kopa Z,Portman MD,Ross JD,Skerlev M,Wilson JD,Patel R, The 2016 European guideline on the management of epididymo-orchitis. International journal of STD     [PubMed PMID: 28632112]
[12] Pilatz A,Boecker M,Schuppe HC,Wagenlehner F, [Current Aspects of Epididymo-Orchitis]. Aktuelle Urologie. 2016 May;     [PubMed PMID: 27123660]
[13] Yung CF,Andrews N,Bukasa A,Brown KE,Ramsay M, Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerging infectious diseases. 2011 Apr;     [PubMed PMID: 21470456]
[14] Nicholson A,Rait G,Murray-Thomas T,Hughes G,Mercer CH,Cassell J, Management of epididymo-orchitis in primary care: results from a large UK primary care database. The British journal of general practice : the journal of the Royal College of General Practitioners. 2010 Oct;     [PubMed PMID: 20883615]
[15] Ryan L,Daly P,Cullen I,Doyle M, Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones. European journal of clinical microbiology     [PubMed PMID: 29450767]
[16] Ibrahim AA,Refeidi A,El Mekki AA, Etiology and clinical features of acute epididymo-orchitis. Annals of Saudi medicine. 1996 Mar;     [PubMed PMID: 17372435]